WAKT er et oppstartsselskap basert i Drammen. Våre kompetanseområder ligger innenfor: Robotic Process Automation Development,Data EngineeringMachine LearningQuantitative financial Engineering and Analysis.Application Development Vi streber etter å ta i bruk moderne teknologi for å levere resultatene vi eller våre kunder er ute etter.

Amina Charging is a technology startup on a mission to give our planet a greener future by scaling the transition to electric vehicles (EV). We create environmental sustainability solutions grounded in sound business and global scalability. We work and play with curiosity, creativity and ambition. At Amina, we never compromise on sustainability, scale and sound business. We work with passion and insight, and prize impact and progress over process. We empower your creative autonomy but you will never struggle alone. We work as a team in an open culture that rewards sharing ideas and supporting each other.

Iterate is an ecosystem for digital innovation, and we like to describe ourselves as a company that builds companies. We contribute from A-Z when building, starting with creating concepts based on key insights to launching and improving products whilst living in the marketplace. We find the right team and work toward the company culture that enables us to deliver value to our customers quickly. The key to achieving this is reinvesting all our profits in the ideas of our employees, or selected entrepreneurs. Five years into this strategy, we own shares in fifteen ventures; all of which are showing promising results. Our 70 designers, developers, and product managers just moved into new locations in the center of Oslo. 
Close collaboration with our customers is key to our success. They provide domain know-how, and we provide tools, strategies, and experts. Together we uncover the best way that connects your strategy and idea with the market needs. Our goal is to achieve minimum risk and give our customers the best possible starting point for scaling, on their own, or in continued collaboration.

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

The world’s largest brands use Mevo to motivate, inform and incentivize frontline retail salespeople to sell more and build brand loyalty. Mevo connects brands to external sales teams. A fully branded sales contest app makes sure brands stay top of mind where it counts the most. EDUCATE & MOTIVATE with product training, challenges, contests, and more through sales and training gamification software.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Octaos is an IT development company, creating modern web-based products to support the processes of the building industry. We make online graphical product configurators fully integrated with the manufactures ERP-systems, for use in both for the professional and the consumer market. Today we have customers in Norway, Sweden and in the UK, - and we have plans to soon grow beyond these business areas.

ICT is a Norwegian technology development company that holds patents designed to bring new opportunities to the cryogenic liquids storage and transportation sectors via unique containers. The design targets the market for both large- and small-scale cryogenic applications. ICT’s solution is modular and suited for onshore as well as maritime use. The development of hydrogen infrastructure is slow and holding back widespread adoption. Transportation of large volumes is one of the major challenges that IC Technologies is determined to solve. Another challenge is the storage of liquid hydrogen. Current storage solutions resemble enlarged thermos flasks, and the hydrogen inside gradually evaporates over time. Our vision is a decarbonized world with green hydrogen as a major energy carrier.

Bad Forecasts Kill Businesses: Working capital cost, natural resource waste, overproduction, lost sales... MIR is the Sherlock Holmes for your business. We identify the most important influence factors out of billions of market data for maximum profit, minimum waste, thanks to the best forecasting accuracy.

We are the tailoring revolution. Based on a profound value for money proposition, we are changing the menswear industry, taking the ancient craft of bespoke, from niche to norm with a modern approach. We want to make custom tailoring the industry standard, shifting the focus from the massive production of ill-fitting standardized garments, to a mass customization production similar to the shift seen in the automobile industry. We strive everyday to refine our products, our customer journey and to bring down leadtimes to make custom tailoring a no-brainer for your next wardrobe investment. Mond of Copenhagen was founded in 2011 by the two brothers Michael and Martin Birch Jacobsen with a vision to shift the industry from mass produced standard sizes, to custom garments, made from scratch to each individual customer. Through innovative technology, lean production methods and industry leading service, Mond quickly grew to become the biggest custom brand in Denmark. With 4 stores in Denmark, Norway and Germany, and a growing team of custom clothiers, Mond is creating a unique customer experience putting the customer front and center in the entire process. Join our team, and help us expand "The tailoring revolution"

SynPlan is an Artificial Intelligence/Machine Learning (AI/ML) solution to help healthcare organisations optimise workforce planning. SynPlan helps collect large amounts of data from a variety of sources, including internal (payroll, accounting,..) and external (weather,…) systems. Having this data presented on a dashboard allows healthcare leaders to get a holistic view of their organization in real-time, instead of waiting for their subordinates to collect data from multiple departments, which might take weeks to months. SynPlan uses advanced Artificial Intelligence technology to predict in advance the demand of healthcare as well as the absence of employees. The healthcare planners can adjust their plans, moving the right resources to where or when it needed the most. By using SynPlan, healthcare leaders can focus their time and energy on patient care rather than planning, improving both the well-being of patients and employees while keeping their SynPlan has a mission to ensure a better life for all healthcare workers and increase the quality of healthcare services. Our ambition is to go internationally to serve more than 20,000 hospitals and healthcare organisations worldwide.

Pretty miserable out there, isn’t it? We’re in the business of spreading smiles. Glede is a micro gifting platform that enables users to send gifts to friends, family, and co-workers. Through Glede you can send everything from a cup of coffee to a bouquet of flowers, or an experience. Glede makes the sending and receiving of gifts spontaneous, fun, and easy!

Startup Migrants is a company based in Berlin and Oslo. We help cities to boost job creation. We are passionate about collecting and analyzing data that can help cities to solve their challenges. Our data is collected from 15 countries, 45 cities and over 200 in depth interviews with policy makers, entrepreneurs, NGOs and migrant founders. We also have created Startup Preschool, a 3-day crash course in entrepreneurship with and for young multicultural talents. We have so far done 84 Preschools and planning to many more in Norway, Germany, Austria and the UK and other countries. Our more than 1000 participants are now part of an acive alumni group and go on applying to accelerators and starting companies.

Speedfriending is a Scandinavian startup aiming to create social arenas where strangers meet, talk and friend zone each other. We want to simplify connecting to the social grid, wherever you are. We have recently launched our Speedfriending app, while organizing events all over Norway, Denmark and Australia. We are looking for someone who loves challenges, has a can-do-attitude, and who recognize the great impact this can have in eliminating loneliness and friendzoning the world. You will become a very important part of our team and future! (More information about us: https://linktr.ee/speedfriending_com) This is speeddating's friendly, fun and inclusive twin sister. After organizing well over 80 physical Speedfriending-events in Norway and Denmark - creating thousands of conversations and friendships - Covid 19 interrupted us. During this time have started digitizing the concept, with an Tinder-for-friends app and a video communication platform. Hope you want to join us. Best regards, The Speedfriending team www.speedfriending.com

We help: 🚀 Entrepreneurs build the foundation for a profitable scalable business and raise money from investors 🦄 We invest in B2B Post Revenue Nordic companies 💌 We continuously share knowledge via our channels and newsletter to empower the startup community. And we do much more. We are always on the move. We are a team of angel investors and startup advisors here to support entrepreneurs, CEOs and leaders reach new heights.